NCT03869762 2024-09-25
DICE
Cancer Trials Ireland
Phase 2 Terminated
Clinical Trials
4 trialsNCT02470091 2024-01-22
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Children's Oncology Group
Phase 2 Completed
NCT03620149 2021-01-06
REDUCE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT03532087 2020-01-18
PERIDENO
Borstkanker Onderzoek Groep
Phase 2 Withdrawn